The widely reported claims that Avandia causes a large increase in heart disease risk could be inconclusive, according to another study published in the New England Journal of Medicine.
Researchers in the study couldn’t be sure that Avandia, heart attacks and heart disease were associated. However, researchers found that Avandia and heart failure were strongly associated.
The heart risk of the drug hit headlines earlier this year, when another study linked Avandia and heart attack and death. The manufacturer of Avandia, GlaxoSmithKline, called the findings and report flawed due to their basis on meta-analysis.
The study was accompanied by several editorials that weigh up the positives and negatives of the drug. Whatever the conclusion of a final report, Avandia sales have taken a tumble on account of the first study earlier this year.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…